Bu çalışmanın amacıhipertansiyonu olan diyabetli hastalarda kan basıncı kontrol(
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Amaç: Hipertansiyon, tip 2 diyabeti olan hastalarda sık olarakeşlik eden bir hastalıktır.
📊
Temel Bulgular & Veri:Hipertansiyonun tedavisi, diyabetinmakro- ve mikrovasküler komplikasyonlarının azaltılmasın- da oldukça önemli bir yere sahiptir.
💡
Sonuç & Katkı:Bu çalışmanın amacıhipertansiyonu olan diyabetli hastalarda kan basıncı kontrol(
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
Amaç: Hipertansiyon, tip 2 diyabeti olan hastalarda sık olarakeşlik eden bir hastalıktır. Hipertansiyonun tedavisi, diyabetinmakro- ve mikrovasküler komplikasyonlarının azaltılmasın- da oldukça önemli bir yere sahiptir. Bu çalışmanın amacıhipertansiyonu olan diyabetli hastalarda kan basıncı kontrol(
Abstract
Objectives: Hypertension is a common co-morbidity in pa- tients with type 2 diabetes. Management of hypertension is ofparamount importance in reducing macro- and microvascularcomplications of diabetes. The aim of this study is to determine the rate of blood pressure control (
🔖
Bu Makaleye Atıf Yap
NAZLI, C., KAHYA, N. E., EMREN, S. V., YAKAR, S. T., DOLEK, D., KORKMAZ, G., HARMAN, E., TÜTÜNCÜOĞLU, A. P., LEVENT, F. (2022). Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension. Türk Kardiyoloji Derneği Arşivi, Cilt: 42 - Sayı: 8, 733–740. https://ajindex.com/articles/632824
Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 2001;24:1522-7
Sowers JR, Epstein M, Frohlich ED. Diabetes, hyperten- sion, and cardiovascular disease: an update. Hypertension 2001;37:1053-9
Jansson SP, Andersson DK, Svärdsudd K. Mortality trends in subjects with and without diabetes during 33 years of follow- up. Diabetes Care 2010;33:551-6
Arauz-Pacheco C, Parrott MA, Raskin P; American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care 2004;27 Suppl 1:65-7
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hyperten- sion (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) ran- domised trial. HOT Study Group. Lancet 1998;351:1755-62
Tuomilehto J, Rastenyte D, Birkenhäger WH, Thijs L, Anti- kainen R, Bulpitt CJ, et al. Effects of calcium-channel block- ade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med 1999;340:677-84
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the manage- ment of arterial hypertension: the Task Force for the manage- ment of arterial hypertension of the European Society of Hy- pertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-357
Raum E, Lietzau S, Stegmaier C, Brenner H, Rothenbacher D. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany. Pharmacoepidemiol Drug Saf 2008;17:485-94
Aparasu RR, Aparasu A. Hypertension management in out- patient visits by diabetic patients. Res Social Adm Pharm 2008;4:284-91
Gee ME, Janssen I, Pickett W, McAlister FA, Bancej CM, Jof- fres M, et al. Prevalence, awareness, treatment, and control of hypertension among Canadian adults with diabetes, 2007 to 2009. Can J Cardiol 2012;28:367-74